SARS-CoV-2

From Wiktionary, the free dictionary
Jump to navigation Jump to search

Translingual

[edit]
Commons:Category
Commons:Category
Wikimedia Commons has more media related to:
Illustration of the SARS-CoV-2 viral coat

Wikispecies

Etymology

[edit]

SARS-CoV +‎ 2 [1]

Proper noun

[edit]

SARS-CoV-2

  1. (virology) Severe acute respiratory syndrome-related coronavirus 2; a virus which causes COVID-19 coronavirus disease, first discovered in 2019, in an outbreak that started in Wuhan, Hubei, China.

Synonyms

[edit]

(virus):

Hypernyms

[edit]

Hyponyms

[edit]

(virus): The number of variants and their names shows a dynamic growth. See e.g. Variant_of_concern

  • SARS-CoV-2 VOC
  • B.1.1.7 (UK variant, Alpha variant)
  • B.1.351 (South African variant, Beta variant)
  • B.1.1.248 (Brazilian variant, Gamma variant)
  • B.1.617.2 (Delta variant)
  • B.1.1.529 (Omikron variant)

Coordinate terms

[edit]

(virus):

closest known relatives to SARS-CoV-2

(viral components)

  • N501 (spike protein coding)
  • E484 (spike protein coding)
  • K417 (protein coding)
[edit]

(virus):

References

[edit]
  1. ^ BioRxviv, "Severe acute respiratory syndrome-related coronavirus – The species and its viruses, a statement of the Coronavirus Study Group", Alexander E. Gorbalenya, 11 February 2020, International Committee on Taxonomy of Viruses, Coronavirus Study Group

Further reading

[edit]

English

[edit]
English Wikipedia has an article on:
Wikipedia
Micrograph of the SARS-CoV-2 virus particles

Pronunciation

[edit]

Proper noun

[edit]

SARS-CoV-2

  1. (virology) SARS-CoV-2; SARS-related coronavirus 2
    • 2020 April, Lu, Xiaoxia, Liqiong Zhang, Hui Du, Jingjing Zhang, Yuan Y. Li, Jingyu Qu, Wenxin Zhang et al., “SARS-CoV-2 infection in children”, in New England Journal of Medicine, volume 382, number 17, →DOI:
      As of March 10, 2020, the 2019 novel coronavirus (SARS-CoV-2) has been responsible for more than 110,000 infections and 4000 deaths worldwide, but data regarding the epidemiologic characteristics and clinical features of infected children are limited.
    • 2021 June, Krause, Philip R., Thomas R. Fleming, Ira M. Longini, Richard Peto, Sylvie Briand, David L. Heymann, Valerie Beral, Matthew D. Snape, Helen Rees, Alba-Maria Ropero, Ran D. Balicer, Jakob P. Cramer, et al., “SARS-CoV-2 Variants and Vaccines”, in New England Journal of Medicine, →DOI:
      In addition to continuing to track the emergence of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there are four major priorities for the global response to variants of concern.

Synonyms

[edit]

Hypernyms

[edit]

Coordinate terms

[edit]
[edit]